Faculty Bibliography

In yesterday's statement, officials of the diseases centers in Atlanta stressed that the risk that any single transfusion recipient had been infected with the AIDS virus was extremely slight and that the mandatory testing of all donated blood begun in the spring of 1985 has ''virtually eliminated'' the spread of the virus by transfusion. No Firm Guidelines Offered ''Many people are panicking,'' Dr. Johanna Pindyck, director of the blood program, said in an interview. ''Most of them have no reason to worry,'' she added, because the number of contaminated units of donated blood in New York ''is 0.04 percent, which is the national average.'' She said the center had estimated that 418 living people had been infected with the AIDS virus from transfusions provided by the center before April 1985. In an interview yesterday, Dr. Joseph criticized the Federal statement as vague. ''We've always looked to the C.D.C. for clarity on scientific matters,'' Dr. Joseph said. But in this case, he added, the message is ''confused.''

Experiments on rabbits, dogs and monkeys indicate that the vaccine spurs production of what may be antibodies that protect against the AIDS virus. HGP-30 is inexpensive to produce and because it is synthetic it can be given to humans without any risk that it will cause AIDS. Because the core proteins of the AIDS virus are believed to be more stable than those on the surface, which seem to change over time and between viral strains, [Allan Goldstein] theorizes that an HGP-30 vaccine might protect against a wide variety of strains of AIDS. [Jonas Salk] has theorized that a killed-virus vaccine might serve two purposes: to prevent AIDS infection, and to touch off a vigorous immune response in people infected by the virus. Salk, who is working at the Salk Institute in La Jolla, Calif., theorizes that AIDS develops more quickly in some people than others because of their weaker, less persistent immunological reaction

The findings, which are scheduled to be presented this year at conferences on AIDS, are believed to provide the longest perspective on the progression of AIDS. Dr. [Harold S. Jaffe] said the few studies conducted on other groups had covered shorter periods of time, but their results 'look more or less the same - it's in the same ballpark,' he said. The researchers studied a group of 104 men selected from the 6,700, determining when infection within the AIDS virus occurred and when the onset of disease began. The researchers have confidence in the results because they used a standard statistical analysis to take account of the small size of the sample and subgroups within it as well as other variables that could have skewed the findings

''The longer one is infected, the higher are the chances of developing AIDS,'' said Dr. George Rutherford of the San Francisco Health Department. ''There doesn't seem to be anything obvious that people can do to stop this disease progression,'' Dr. [Harold S. Jaffe] said in an interview. The findings, which are scheduled to be presented this year at conferences on AIDS, are believed to provide the longest perspective on the progression of AIDS. Dr. Jaffe said the few studies conducted on other groups had covered shorter periods of time, but their results ''look more or less the same - it's in the same ballpark,'' he said. Study of Hepatitis B

The findings, which are scheduled to be presented this year at conferences on AIDS, are believed to provide the longest perspective on the progression of AIDS. Dr. [Harold Jaffe] said the few studies conducted on other groups had covered shorter periods of time, but their results ''look more or less the same - it's in the same ballpark.'

''The overriding reason,'' Dr. [John Martin] said, was concern that the names of the subjects would not be kept confidential. ''No matter what we told the people, they believed that if insurance companies or the Government wanted to get their hands on their names, they could,'' he recalled. Dr. James O. Mason, the director of the Centers for Disease Control, opened the meeting by describing AIDS as ''an unprecedented epidemic'' and calling for public health officials to ''learn how to strengthen confidentiality.'' He warned that unless strong measures were taken, those most in need of testing might avoid the health system. ''The lack of a national policy on AIDS is a tragedy and a disgrace,'' said Dr. Mervyn F. Silverman, president of the American Foundation for AIDS Research. ''If we had a national policy, we might also have a national policy on confidentiality and on discrimination, and if we had those policies in place this meeting very likely would not have been necessary.''

Part of the mystery and fear about AIDS arises from the fact that many carriers of the virus are not aware of it. The virus can lurk in the body without causing disease and, among those who develop AIDS, the average time between infection and diagnosis may be five years or more. A: Experts estimate that up to 1.5 million Americans are infected with the AIDS virus. Most are homosexual men and intravenous drug users, but a small, perhaps growing portion are men or women who were infected through heterosexual intercourse with a drug user or a bisexual man. Each infected person is presumed to be capable of spreading the virus to others through sexual intercourse or through blood, as in sharing contaminated needles. A: The blood test for AIDS infection detects the presence of AIDS virus antibodies, substances the body produces in response to invasion by the virus. Those who fear they may be infected can get the blood test through a personal doctor or through anonymous testing centers in many cities

Dr. [Robert J. Levine] of Yale noted that many participants used the terms ''routine,'' ''anonymous,'' ''standard,'' ''required'' and ''confidential'' in many different ways with respect to AIDS testing